SplitJul 13, 2026, 04:07 PM
Galera Therapeutics Effects 1-for-200 Reverse Stock Split
AI Summary
Galera Therapeutics, Inc. implemented a one-for-two hundred reverse stock split of its common stock, effective July 12, 2026. The company's common stock began trading on a split-adjusted basis on the OTCQB Market under the new ticker symbol "GRTXD" on July 13, 2026. This action resulted in a proportionate reduction in the number of shares available under equity plans and issuable upon exercise of outstanding stock options and warrants, with corresponding adjustments to their exercise prices. Fractional shares will be compensated with cash.
Key Highlights
- Galera Therapeutics effected a one-for-two hundred (1:200) reverse stock split.
- The amendment to the Certificate of Incorporation became effective on July 12, 2026, at 11:59 p.m. ET.
- Common Stock began trading on a split-adjusted basis on the OTCQB Market on July 13, 2026, under ticker "GRTXD".
- The split reduced shares available under equity incentive plans and issuable upon exercise of options and warrants.
- Exercise prices for outstanding stock options and warrants were proportionately increased.
- No fractional shares will be issued; stockholders will receive cash value for fractional shares.
Price Impact
More from GRTX